Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02926079 · ClinicalTrials.gov registry record
Investigation of Mechanisms for Transmission of Impaired Glucose Metabolism in Infants Exposed to Diabetes in Utero
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 18
- Enrollment target
NCT02926079 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 18 participants.
The verdict
NCT02926079 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This proposed study; Investigation of mechanisms for transmission of impaired glucose metabolism in infants exposed to diabetes in utero, will test the overarching hypothesis that impaired maternal substrate oxidation (metabolic inflexibility) and placental lipotoxicity are characteristics of diabetic pregnancies and in utero development within these conditions programs a metabolically inflexible phenotype in the offspring.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-05-23 |
| Est. Completion | 2019-01-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02926079
The ClinicalTrials.gov registry entry for NCT02926079 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02926079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02926079 about?
NCT02926079 is a clinical study titled "Investigation of Mechanisms for Transmission of Impaired Glucose Metabolism in Infants Exposed to Diabetes in Utero". This proposed study; Investigation of mechanisms for transmission of impaired glucose metabolism in infants exposed to diabetes in utero, will test the overarching hypothesis that impaired maternal substrate oxidation (metabolic inflexibility) and placental lipotoxicity are characteristics of diabet...
What is the current status of trial NCT02926079?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2017-05-23. Estimated completion is 2019-01-08.
Who is sponsoring clinical trial NCT02926079?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.